|
|
| Sun Pharmaceutical Industries Limited |
|
Financials-Sun Pharmaceutical Industries Limited| Sector: Bulk Drugs and Formulations | | BSE:524715 | NSE:SUNPHARMA | Bloomberg:SUNP@IN | Reuters:SUN.BO | | Market Lot: 1 | Face Value: 1 | ISIN Demat: INE044A01036 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2021(3) |
31-Mar-2020(3) |
% Change |
| Sales of Products/Services |
31596.40 |
28360.80 |
11.41 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
348.70 |
12186.50 |
-97.14 |
| Total Income |
31945.10 |
40547.30 |
-21.22 |
| Total Expenses |
-27338.80 |
-28875.10 |
-5.32 |
| OPBDIT |
59283.90 |
69422.40 |
-14.60 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-1517.60 |
-28875.10 |
-94.74 |
| Exceptional & Extraordinary Items |
-895.60 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-436.80 |
-113.70 |
284.17 |
| After Tax Profit |
3273.90 |
11558.50 |
-71.68 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-08(12) |
|
31-Mar-07(12) |
|
31-Mar-06(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
30856.60 |
99.54 |
21915.50 |
98.22 |
16409.50 |
98.17 |
| Operating Income (OI) |
30999.40 |
100.00 |
22313.80 |
100.00 |
16715.10 |
100.00 |
| OPBDIT |
9886.10 |
31.89 |
5656.70 |
25.35 |
4355.20 |
26.06 |
| OPBDT |
9886.10 |
31.89 |
5656.70 |
25.35 |
4355.20 |
26.06 |
| OPBT |
9325.00 |
30.08 |
5194.00 |
23.28 |
3947.90 |
23.62 |
| Non-Operating Income |
1197.00 |
3.86 |
1211.40 |
5.43 |
938.90 |
5.62 |
| Extraordinary/Prior Period |
-36.20 |
-0.12 |
-48.80 |
-0.22 |
-191.40 |
-1.15 |
| Tax |
345.40 |
1.11 |
67.30 |
0.30 |
82.50 |
0.49 |
| Profit after tax(PAT) |
10140.40 |
32.71 |
6289.30 |
28.19 |
4612.90 |
27.60 |
| Cash Profit |
10701.50 |
34.52 |
6752.00 |
30.26 |
5020.20 |
30.03 |
| Dividend-Equity |
2175.20 |
7.02 |
1300.10 |
5.83 |
1023.00 |
6.12 |
|
| As on |
31-Mar-08 |
|
31-Mar-07 |
|
31-Mar-06 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
8905.70 |
16.49 |
7943.10 |
20.63 |
6998.70 |
19.53 |
| Net Block |
6130.30 |
11.35 |
5693.50 |
14.79 |
5128.70 |
14.31 |
| Capital WIP |
334.30 |
0.62 |
319.10 |
0.83 |
308.00 |
0.86 |
| Investments |
17346.70 |
32.11 |
9394.80 |
24.40 |
6545.60 |
18.27 |
| Inventory |
3896.30 |
7.21 |
3333.80 |
8.66 |
2634.10 |
7.35 |
| Receivables |
10554.40 |
19.54 |
3100.00 |
8.05 |
2564.70 |
7.16 |
| Other Current Assets |
15754.50 |
29.17 |
16665.10 |
43.28 |
18651.30 |
52.05 |
| Balance Sheet Total(BT) |
54016.50 |
100.00 |
38506.30 |
100.00 |
35832.40 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
1035.60 |
1.92 |
967.00 |
2.51 |
928.70 |
2.59 |
| Reserves |
40870.50 |
75.66 |
23314.80 |
60.55 |
13473.50 |
37.60 |
| Total Debt |
1025.20 |
1.90 |
10695.20 |
27.78 |
17472.20 |
48.76 |
| Creditors and Acceptances |
6464.80 |
11.97 |
674.50 |
1.75 |
769.60 |
2.15 |
| Other current liab/prov. |
4620.40 |
8.55 |
2854.80 |
7.41 |
3188.40 |
8.90 |
| Balance Sheet Total(BT) |
54016.50 |
100.00 |
38506.30 |
100.00 |
35832.40 |
100.00 |
|
| As on |
31-Mar-08 |
31-Mar-07 |
31-Mar-06 |
| OPBIT/Prod.cap.empl.(%) |
38.59 |
21.57 |
16.61 |
| PBIT/Cap. Employed (%) |
24.62 |
18.34 |
14.87 |
| PAT/Networth (%) |
24.20 |
25.90 |
32.03 |
| Tax/PBT (%) |
3.29 |
1.06 |
1.76 |
| Total Debt/Networth (x) |
0.02 |
0.44 |
1.21 |
| Long Term Debt/Networth (x) |
0.02 |
0.43 |
1.20 |
| PBDIT/Finance Charges (x) |
0.00 |
0.00 |
0.00 |
| Current Ratio (x) |
2.72 |
6.54 |
6.03 |
| RM Inventory (days consumption) |
174.59 |
160.33 |
-1579.64 |
| FG inventory (days cost of sales) |
13.92 |
18.96 |
17.35 |
| Receivables (days gross sales) |
122.51 |
50.26 |
54.99 |
| Creditors (days cost of sales) |
111.76 |
14.78 |
22.73 |
| Op. curr. assets (days OI) |
330.00 |
333.00 |
493.00 |
|
|
Financials